Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 31, Issue 19, Pages 2428-2436
Publisher
American Society of Clinical Oncology (ASCO)
Online
2013-05-21
DOI
10.1200/jco.2012.47.3314
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clonal architecture of chronic myelomonocytic leukemias
- (2013) R. Itzykson et al. BLOOD
- Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes
- (2012) F. Damm et al. BLOOD
- SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
- (2012) M. Meggendorfer et al. BLOOD
- A novel hierarchical prognostic model of AML solely based on molecular mutations
- (2012) V. Grossmann et al. BLOOD
- Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis
- (2012) H. Makishima et al. BLOOD
- ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
- (2012) Omar Abdel-Wahab et al. CANCER CELL
- Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases
- (2012) S. Schnittger et al. HAEMATOLOGICA
- Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia
- (2012) S. A. Kar et al. HAEMATOLOGICA
- Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
- (2012) Rafael Bejar et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
- (2012) Véronique Gelsi-Boyer et al. Journal of Hematology & Oncology
- Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association
- (2012) A Renneville et al. LEUKEMIA
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
- (2012) Jay P. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A
- (2011) A. M. Jankowska et al. BLOOD
- New mutations and pathogenesis of myeloproliferative neoplasms
- (2011) W. Vainchenker et al. BLOOD
- Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial
- (2011) T. Braun et al. BLOOD
- Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies
- (2011) Z. Li et al. BLOOD
- Current status of allogeneic HST for chronic myelomonocytic leukemia
- (2011) H Cheng et al. BONE MARROW TRANSPLANTATION
- Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia
- (2011) Ulrike Bacher et al. BRITISH JOURNAL OF HAEMATOLOGY
- TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis
- (2011) Cyril Quivoron et al. CANCER CELL
- Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
- (2011) Kelly Moran-Crusio et al. CANCER CELL
- Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System
- (2011) Julie Schanz et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance
- (2011) V Grossmann et al. LEUKEMIA
- Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms
- (2011) O Abdel-Wahab et al. LEUKEMIA
- DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms
- (2011) O Abdel-Wahab et al. LEUKEMIA
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- Clinical Effect of Point Mutations in Myelodysplastic Syndromes
- (2011) Rafael Bejar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice
- (2011) M. Ko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value
- (2010) A. E. Smith et al. BLOOD
- ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia
- (2010) Véronique Gelsi-Boyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Activity of azacitidine in chronic myelomonocytic leukemia
- (2010) Rubens Costa et al. CANCER
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- Cytogenetic risk stratification in chronic myelomonocytic leukemia
- (2010) E. Such et al. HAEMATOLOGICA
- Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1
- (2010) Alexander Kohlmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms
- (2010) O Kosmider et al. LEUKEMIA
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
- (2010) Thomas Ernst et al. NATURE GENETICS
- Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms
- (2009) A. M. Jankowska et al. BLOOD
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Mutations of polycomb-associated geneASXL1in myelodysplastic syndromes and chronic myelomonocytic leukaemia
- (2009) Véronique Gelsi-Boyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia
- (2009) O. Kosmider et al. HAEMATOLOGICA
- Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies
- (2009) Hideki Makishima et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation
- (2009) M-C Kuo et al. LEUKEMIA
- High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients
- (2008) J. W. Tyner et al. BLOOD
- Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1genes
- (2008) Véronique Gelsi-Boyer et al. BMC CANCER
- Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
- (2008) Hagop Kantarjian et al. CANCER
- 250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid Malignancies
- (2008) A. J. Dunbar et al. CANCER RESEARCH
- Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)
- (2007) P.W. Wijermans et al. LEUKEMIA RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started